Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Microbicide Post-Marketing Surveillance Proposed By Industry

This article was originally published in The Tan Sheet

Executive Summary

Appropriate post-marketing surveillance measures would enable industry to detect rare adverse reactions caused by OTC microbicides, thereby allowing consumers to access the products without the Rx hurdle, an industry official told FDA June 29.

You may also be interested in...



Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results

Appointment of an outside team of investigators to independently review the nonoxynol-9 data generated by the UNAIDS Phase III efficacy trial in the prevention of male-to-female HIV transmission is being urged by Columbia Laboratories.

Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results

Appointment of an outside team of investigators to independently review the nonoxynol-9 data generated by the UNAIDS Phase III efficacy trial in the prevention of male-to-female HIV transmission is being urged by Columbia Laboratories.

Nonoxynol-9 Spermicides May Need Review After Clinical Trial Results

Appointment of an outside team of investigators to independently review the nonoxynol-9 data generated by the UNAIDS Phase III efficacy trial in the prevention of male-to-female HIV transmission is being urged by Columbia Laboratories.

Topics

UsernamePublicRestriction

Register

PS091413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel